Capstone Investment Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Capstone Investment Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,500	Closed	-$232K	–	1171
2016 Q3	$232K	Buy	+9,500	New	+$237K	0.01%	657

Capstone Investment Advisors's AMAG Position: Q4 2016 in Review

Capstone Investment Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2016, closing a stake of 9,500 shares — an estimated $232K sold.

Capstone Investment Advisors first reported a position in AMAG in Q3 2016 and held it in 1 quarter. The position peaked at $232K in Q3 2016. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

Capstone Investment Advisors reported no remaining AMAG Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Capstone Investment Advisors sold 9,500 AMAG Pharmaceuticals shares in Q4 2016, an estimated $232K.
Capstone Investment Advisors first reported a position in AMAG Pharmaceuticals in Q3 2016 and held it in 1 quarter.
Capstone Investment Advisors's AMAG Pharmaceuticals position peaked at $232K in Q3 2016.
206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on Capstone Investment Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.